
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses how health information technology rules improve oncology clinic practices.
Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses how health information technology rules improve oncology clinic practices.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.






